[go: up one dir, main page]

GB1372175A - 3alpha-hydroxy-pregn-4-enes - Google Patents

3alpha-hydroxy-pregn-4-enes

Info

Publication number
GB1372175A
GB1372175A GB5303870A GB5303870A GB1372175A GB 1372175 A GB1372175 A GB 1372175A GB 5303870 A GB5303870 A GB 5303870A GB 5303870 A GB5303870 A GB 5303870A GB 1372175 A GB1372175 A GB 1372175A
Authority
GB
United Kingdom
Prior art keywords
prepared
hydroxy
dione
pregn
hydroxypregn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5303870A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Priority to GB5303870A priority Critical patent/GB1372175A/en
Priority to BE774988A priority patent/BE774988A/en
Priority to AU35398/71A priority patent/AU470121B2/en
Priority to DE19712155137 priority patent/DE2155137A1/en
Priority to CA126,960A priority patent/CA981251A/en
Priority to DK542071AA priority patent/DK128898B/en
Priority to FR7139810A priority patent/FR2112503B1/fr
Priority to ZA717449A priority patent/ZA717449B/en
Priority to NL7115297A priority patent/NL7115297A/xx
Priority to IL38112A priority patent/IL38112A/en
Publication of GB1372175A publication Critical patent/GB1372175A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)

Abstract

1372175 3α-Hydroxy-pregn-4-enes and their esters GLAXO LABORATORIES Ltd 5 Nov 1971 [6 Nov 1970] 53038/70 Heading C2U [Also in Division A5] Novel pregn-4-enes and 19-nor-pregn-4-enes, excluding 3α-hydroxypregn-4-en-20-one, possess a 3α-(free or esterified hydroxy group) group, a 17#-acetyl group together with a 17α-hydrogen atom, and in the 11-position two hydrogen atoms or an oxo group. The esterified hydroxy group is derived from an optionally carboxy- or halosubstituted C 1-5 alkanoic acid. The steroids may contain further substituents in undefined positions, particularly in the 2- and 16- positions, e.g. 16-CH 3 and 2#-(alkyl, alkoxy and halo). They may be prepared, for example, (a) by nucleophilic displacement of an allylically replaceable 3#-substituent in a suitable steroid containing a 2#-hydrogen atom by the required 3α-(free or esterified hydroxy group); or (b) for a product containing a 2#-substituent, by reacting an appropriate 2α,3α-epoxy-5α-ol with R<SP>2</SP>H (R<SP>2</SP> is C 1-5 alkyl, C 1-6 alkoxy or halogen) or a compound furnishing an anion R<SP>2-</SP> and a cation to give the corresponding 2#-R<SP>2</SP>-3α-ol (or a metal salt thereof) followed by treatment with a proton source when necessary and then dehydration to form the #<SP>4</SP>-double bond, the 3α-OH group being protected during dehydration and subsequently released. Resulting 3α-ols may subsequently be esterified. In one example 3#-dichloroacetoxypregn-4-en- 20-one (prepared from the free 3#-ol and dichloroacetyl chloride) is refluxed with an acetate buffer solution to give, in addition to the required 3α-ol, some 3#-hydrozy-pregn-4-en-20-one and 5α - hydroxy - pregn - 3 - en - 20 - one; the last-mentioned is separated from the 3α-ol by preparative T.L.C. and the 3#- and 3α-ols, and other similarly formed 3α- and 3#-ol mixtures, are separated via the digitonin complexes of the 3#-ols. In another example dehydration of 3α- acetoxy - 5α - hydroxy - 2# - methoxypregnan- 20-one gives not only the required #<SP>4</SP>-compound but also 3α-acetoxy-2#-methoxypregn-5-en-20- one. 3# - Hydroxypregn - 4 - ene - 11,20 - dione is prepared by converting 3-[pyrrolidin-1-yl)- pregna -3,5 - dien - 11,20 - dione (prepared from 11-oxo-progesterone and pyrrolidine) to the enaminium chloride, reacting this with ethyleneglycol and hydrolysing to give 20,20-ethylenedioxypregn - 4 - ene - 3,11 - dione, reducing this to 20,20-ethylenedioxy-3#-hydroxypregn-4- en-11-one and'hydrolysing this; the intermediate 3,11-dione may alternatively be prepared by oxidation of 20, 20-ethylenedioxy-11α-hydroxypregn-4-en-3-one, in turn prepared by converting 11α - hydroxypregn - 4 - ene - 3,20 - dione to 11α - hydroxy - 3 - (pyrrolidin - 1 - yl) - pregna- 3,5-dien-20-one, converting this to the enaminiurn chloride and reacting this with ethylene glycol and hydrolysing to the 3-one. 3#-Dichloroacetoxypregn - 4 - ene - 11,20 - dione and 3α - acetoxy - 5α - hydroxy - 2# - methoxypregnan- 20-one are prepared by esterification of the corresponding 3-ols, 3α,5α-dihdroxy-2#-methoxypregn-20-one being in turn prepared from 2α,3α- epoxy-5α-hydroxypregnan-20-one and methanol.
GB5303870A 1970-11-06 1970-11-06 3alpha-hydroxy-pregn-4-enes Expired GB1372175A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GB5303870A GB1372175A (en) 1970-11-06 1970-11-06 3alpha-hydroxy-pregn-4-enes
BE774988A BE774988A (en) 1970-11-06 1971-11-05 PREGNANE SERIES COMPOUNDS WITH ANESTHESIC ACTIVITY AND THEIR PREPARATION
AU35398/71A AU470121B2 (en) 1970-11-06 1971-11-05 3&-hydroxy-pregn-4-enes
DE19712155137 DE2155137A1 (en) 1970-11-06 1971-11-05 Pregnan range steroids
CA126,960A CA981251A (en) 1970-11-06 1971-11-05 Compounds of the pregnane series having useful anaesthetic activity
DK542071AA DK128898B (en) 1970-11-06 1971-11-05 Analogous process for the preparation of 3α-oxygenated pregn-4-en-20-ones.
FR7139810A FR2112503B1 (en) 1970-11-06 1971-11-05
ZA717449A ZA717449B (en) 1970-11-06 1971-11-05 Compounds of the pregnane series having useful anaesthetic activity
NL7115297A NL7115297A (en) 1970-11-06 1971-11-05
IL38112A IL38112A (en) 1970-11-06 1971-11-09 3alpha-hydroxy-pregn-4-en-20-one and esters thereof their preparation and anesthetic com positions comprising them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5303870A GB1372175A (en) 1970-11-06 1970-11-06 3alpha-hydroxy-pregn-4-enes

Publications (1)

Publication Number Publication Date
GB1372175A true GB1372175A (en) 1974-10-30

Family

ID=10466377

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5303870A Expired GB1372175A (en) 1970-11-06 1970-11-06 3alpha-hydroxy-pregn-4-enes

Country Status (10)

Country Link
AU (1) AU470121B2 (en)
BE (1) BE774988A (en)
CA (1) CA981251A (en)
DE (1) DE2155137A1 (en)
DK (1) DK128898B (en)
FR (1) FR2112503B1 (en)
GB (1) GB1372175A (en)
IL (1) IL38112A (en)
NL (1) NL7115297A (en)
ZA (1) ZA717449B (en)

Also Published As

Publication number Publication date
CA981251A (en) 1976-01-06
AU3539871A (en) 1973-05-10
DE2155137A1 (en) 1972-05-10
DK128898B (en) 1974-07-22
ZA717449B (en) 1973-06-27
AU470121B2 (en) 1976-03-04
FR2112503A1 (en) 1972-06-16
IL38112A (en) 1977-06-30
FR2112503B1 (en) 1975-11-28
NL7115297A (en) 1972-05-09
IL38112A0 (en) 1972-03-28
BE774988A (en) 1972-05-05

Similar Documents

Publication Publication Date Title
GB1475795A (en) Steroid 21-thioesters
IL72702A0 (en) Steroidal carboxylic acid esters,their manufacture and pharmaceutical compositions containing them
GB1478357A (en) Haptene derivatives of estrogens processes for preparing them and methods of preparing antigens from them
GB1372175A (en) 3alpha-hydroxy-pregn-4-enes
GB1037162A (en) Improvements in or relating to 19-oxo-androstane compounds and derivatives thereof
GB1147801A (en) Improvements in or relating to novel steroids and the manufacture thereof
US2837517A (en) 9, 11beta-epoxy-17-alkyltestosterones
GB1277266A (en) 07-acetylgonanes and derivatives therefor
GB1352027A (en) Process for the manufacture of pregnane compounds and process for the manufacture of sulphite esters
GB1099008A (en) Novel unsaturated steroids, and processes for their preparation
GB1365205A (en) Process for the manufacture of 17-/2-haloalkylidene/-steroids
GB1514621A (en) 13-ethynyl-and 13-(2-halovinyl)-steroids and their preparation
ES400163A1 (en) Novel pregnanoic acid derivatives
GB1303008A (en)
GB921534A (en) Cyclopentanophenanthrene derivatives and process for the production thereof
GB1130189A (en) Improvements in or relating to steroid intermediates and the production thereof
GB973328A (en) Steroid compounds
GB980245A (en) New-6-alkyl-steroids
GB976818A (en) 4-alkanoylthio- and 4-aroylthio-3-keto-í¸-steroids and process for the preparation thereof
GB1101791A (en) New 1ª‡:7ª‡-dimethyl steroids and a process for their manufacture
GB1255186A (en) New 22,25-epoxy-steroids and a process for their manufacture
GB1003305A (en) Novel steroid compounds and their preparation
GB973899A (en) Novel steroid compounds and their preparation
GB1053214A (en)
GB1061036A (en) Steroidal 6-chloro-4,6-dienes and preparation thereof

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
429A Application made for amendment of specification (sect. 29/1949)
429H Application (made) for amendment of specification now open to opposition (sect. 29/1949)
429D Case decided by the comptroller ** specification amended (sect. 29/1949)
PCNP Patent ceased through non-payment of renewal fee